ArticleJournal of rheumatic diseases2024

Anemia as an indicator of a higher retention rate for tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis from a Korean multi-center registry.

Jung Gon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.